[Sustained reduction of fracture risk in high compliance].  [electronic resource] 

 -  MMW Fortschritte der Medizin  Jul 2015 
 - 86-7 p.  digital 
<br/><br/> Publication Type: News; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1438-3276 
<br/><br/><label>Standard No.: </label>10.1007/s15006-015-3325-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Denosumab--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Osteoporotic Fractures--prevention & control<br/>Patient Compliance<br/>Risk Factors